newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

Prioritizing and focusing on highest-value opportunities NC410 (ovarian and CRC) and LNCB74 (B7-H4 ADC)Based on early evidence of clinical activity with NC410 combo, expanding ovarian and CRC cohorts with data updates in